Do You Need a License to Sell Peptides in Maine?

There is no single credential called a "peptide license," in Maine or anywhere else. What you actually need depends on which lane your business operates in: ordinary business registration to transact at all, a drug or wholesale-distributor credential if you are handling products positioned for human use, or standard business paperwork plus disciplined documentation if you are purchasing and reselling research-use-only material that never enters a human-use channel. Which lane applies to your specific catalog and customer base is a legal question for your own attorney and the relevant Maine authorities — this article explains the framework and the questions to ask, and it is informational only, not legal advice.

That distinction is the whole ballgame. Buyers who get into trouble usually do not fail a licensing test; they blur two lanes together, then discover that the paperwork they filed answered a different question than the one a regulator was asking.

Three separate questions, three different authorities

When someone asks whether a license is required, they are almost always compressing three unrelated questions into one. Separating them is the first useful step, because no single office can answer all three.

Can my business legally exist and transact? This is entity formation and registration — the layer handled by state business filings, municipal requirements where they apply, and sales or resale tax registration. It has nothing to do with peptides specifically. Nearly every state maintains some version of this requirement for businesses selling goods, and the specifics change by entity type and locality, so confirm current requirements with the appropriate state office rather than relying on a summary.

What is the product, in regulatory terms? This is classification, and it is the question that determines whether any additional credential enters the picture at all. Research-use-only compounds, finished drug products, dietary supplements, and cosmetics sit in different regulatory buckets with different rules attached. Ask your attorney how classification analysis applies to each item you intend to stock — not as a general topic, but item by item.

Does the specific activity trigger a professional or distribution credential? Storing, reselling, relabeling, repackaging, shipping, or anything involving a licensed practitioner's scope of practice can each pull in a different rulebook. Two businesses can stock identical material and face different obligations because one only resells sealed vials to other businesses and the other does something further with them.

Write those three questions down separately before you call anyone. Otherwise you will get a partial answer from a source that only ever had jurisdiction over one third of the problem.

Why product classification drives every other answer

Everything downstream — labeling, marketing copy, who you can sell to, what records you keep — follows from classification. And a recurring theme in regulatory practice is that how a product is described and marketed carries weight in how it gets classified. That is worth putting to counsel directly: ask how intended-use analysis would apply to your website, your catalog descriptions, your invoices, and the way your staff answers the phone.

The practical consequence for a research-use-only catalog is that consistency is not a marketing preference, it is the load-bearing wall. Research-use-only material is supplied for laboratory research. It is not an approved drug, it is not supplied for human consumption, and no part of your sales process should describe it as though it were. That means no dosing information, no administration guidance, no protocols, no before-and-after outcomes, no implied endorsement of use in people. If any marketing asset in your business contradicts the classification your paperwork depends on, you have created the exact ambiguity a regulator or an insurer would eventually ask about.

This is also where a lot of otherwise careful operators drift. The compound science is genuinely interesting — research suggests a wide range of mechanisms across peptide classes, and studies indicate active investigation in many directions — but "research suggests" is where the sentence stops. Discussing what a compound does in a research context is different from telling a buyer what it will do for a person. Keep your language on the first side of that line and keep it there in every channel.

If any part of your operation touches animal-model research or a veterinary setting, talk to your veterinarian as well as your attorney before placing an order; scope and recordkeeping questions in that context run through a different licensing body entirely.

Who answers what, and what to bring them

Most of the frustration in this process comes from asking the right question to the wrong office. Use this as a routing map, not as a legal conclusion — verify each item for your own situation.

One caution on this table: a phone call to a state office is useful for procedural questions and unreliable as legal cover. Get anything consequential in writing, and treat verbal guidance as a lead to verify rather than a ruling to rely on.

The documentation layer you actually control

You cannot control how rules evolve. You can control whether your file holds up when someone asks. In practice, the businesses that navigate this cleanly maintain a boring, complete paper trail:

• Entity and tax records current and matched to the name on your invoices.
• Certificates of analysis for every batch you receive, filed against the lot number on the vial in your hand — not a generic report for the product line.
• Labeling that matches classification on everything in your possession, including anything you relabel.
• Purchase and sales records showing what came in, what went out, and to whom.
• Marketing review as a recurring task, because website copy drifts. Someone should own the job of reading every page, product description, and email template against your classification.
• Staff scripts for what your team does and does not say when a customer asks a question they should not answer.

The COA-to-batch match deserves emphasis, because it is the item most often skipped and the easiest to check. A certificate that does not reference the specific lot you received tells you almost nothing about the vial on your shelf. If a supplier cannot produce a lot-matched report on demand, your documentation layer has a hole in it that no amount of business licensing will patch.

What to verify in a wholesale supplier before you order

Supplier diligence is not separate from the licensing question; it is the part of the licensing question you can resolve in an afternoon. Work through this before you place a first order:

Are COAs published, or gated? Some suppliers treat lab results as a paid add-on or send unbranded PDFs on request. Others publish reports you can pull up yourself and match to your lot. The second arrangement is verifiable; the first requires you to take the claim on faith.

What testing was actually run? "Third-party tested" with no accessible report is a slogan. Ask what analytical methods were used, what the purity figure is, and what else the batch was screened for beyond purity.

Is pricing published? Hidden pricing is not automatically a red flag, but a program that will not disclose tiers, minimums, or terms until you are deep in a sales conversation makes it impossible to model your own costs. Margins and minimums vary widely by volume and category, so get the actual numbers for your account in writing rather than working from any range you read online.

Where does fulfillment originate, and what happens when something is wrong? Ask about domestic fulfillment, lead times, and the specific process for a short shipment or a batch you want to re-verify.

What is in the catalog, and what is not? Ask plainly. A supplier that is precise about what it does not carry is generally precise about the rest of its documentation too.

What Real Peptides does differently

Real Peptides supplies research-use-only peptides to businesses through its Wholesale Partner Program, and the program is built around the diligence items above rather than around a sales conversation.

Compounds are supplied at 99%+ HPLC purity. Every batch goes through six-panel testing, and the resulting certificates of analysis are publicly verifiable — a prospective buyer can look up the lab results independently and match them to a batch, without asking a representative for a favor or paying for a report. That is the difference between a purity claim and a purity record.

Fulfillment is domestic. As of 2026, Real Peptides lists US fulfillment in 5 to 7 days. Onboarding runs through a three-step wholesale application: submit your business information, get reviewed for qualification, and receive your account and pricing. Nothing in that process substitutes for your own licensing diligence, and Real Peptides does not provide legal advice about your jurisdiction — but it does mean the supplier-side questions on your diligence list arrive answered rather than pending.

Where a qualified business goes from here

If you have separated the three questions, confirmed your entity and tax registration, put the classification question in front of your own counsel, and satisfied yourself that a supplier's testing is verifiable rather than merely asserted, the remaining step is opening an account and getting real pricing to model against. The Wholesale Partner Program application is short, and qualification is decided on your business information rather than on a sales call.

For the broader framework, see do you need a license to sell peptides; program mechanics, testing standards, and terms are outlined on the wholesale peptides program page; and qualified businesses can apply for a wholesale account directly.